Copyright
©The Author(s) 2024.
World J Stem Cells. Feb 26, 2024; 16(2): 191-206
Published online Feb 26, 2024. doi: 10.4252/wjsc.v16.i2.191
Published online Feb 26, 2024. doi: 10.4252/wjsc.v16.i2.191
Level 1 | Level 2 | Level 3 | Level 4 | |
Pain conditions | No significant reaction | Avoidance contraction of the affected limb following compression | Avoided contraction of the affected limb and turn back, body out present tremor | Violent contraction of the affected limb, violent shaking and struggling of the body |
Gait | Normal gait | Mild limp but strong stirring of the affected limb | The limp is pronounced, and the strength of the affected limb to stir on the ground is reduced | The affected limb is afraid to walk on the ground |
Knee range of motion | > 90° | 45°-90° | 15°-45° | < 15° |
Swelling | No swelling and clear bony markings | Mild swelling with superficial bony markings | Significant swelling and loss of bony markings |
- Citation: Yang F, Xiong WQ, Li CZ, Wu MJ, Zhang XZ, Ran CX, Li ZH, Cui Y, Liu BY, Zhao DW. Extracellular vesicles derived from mesenchymal stem cells mediate extracellular matrix remodeling in osteoarthritis through the transport of microRNA-29a. World J Stem Cells 2024; 16(2): 191-206
- URL: https://www.wjgnet.com/1948-0210/full/v16/i2/191.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i2.191